[1] |
Wu Jiayi, Chen Keyu, Shao Xiying, Wang Xiaojia.
Research progress on the mechanism of CDK4/6 inhibitors promoting antitumor immunity by regulating the immune microenvironment of triple negative breast cancer
[J]. Journal of International Oncology, 2022, 49(6): 362-365.
|
[2] |
Wei Yongjian, Hu Jinjing, Li Xun.
Relationship between CDCA8 and tumor progression as well as that between CDCA8 and stemness maintenance of stem cells
[J]. Journal of International Oncology, 2021, 48(4): 216-219.
|
[3] |
Zhang Baihong, Yue Hongyun.
Application of selective CDK4/6 inhibitors in solid cancers therapy
[J]. Journal of International Oncology, 2019, 46(6): 350-357.
|
[4] |
Kang Ye, Li Jianyi, Yang Xianghong.
Research progress of cancer stem cells in triplenegative breast cancer
[J]. Journal of International Oncology, 2019, 46(6): 362-365.
|
[5] |
XU Yao-Zong, GU Xiao, WANG Fei, DING Xue-Fei.
Molecular mechanisms of castrationresistant prostate cancer progressed from prostate cancer by androgen deprivation treatment
[J]. Journal of International Oncology, 2018, 45(8): 506-509.
|
[6] |
Liu Hengyao, Zhao Guoli, Wang Fuwen, Cai Haibo, Zhang Yueying..
Notch signaling pathway in lung cancer and lung cancer stem cells and its inhibitors
[J]. Journal of International Oncology, 2018, 45(4): 250-252.
|
[7] |
Ye Zhihua, Huang Geng, Fu Jinlun, Gui Dingwen.
Effects of miR-1291 on the cell cycle and proliferation of renal cell carcinoma by regulating the expression of Zinc finger protein 8 gene
[J]. Journal of International Oncology, 2018, 45(3): 129-133.
|
[8] |
PENG Yong-Hua, PENG Li, LIANG Zhi-Man, ZHANG Xing-Mei.
Application of aptamer in the study of cancer stem cells
[J]. Journal of International Oncology, 2017, 44(8): 672-675.
|
[9] |
SHEN Ya-Ting, HU Duan-Min.
Anticancer properties of fenofibrate
[J]. Journal of International Oncology, 2017, 44(8): 682-685.
|
[10] |
Tong Yalan, Han Tao, Liu Zhongzheng, Yuan Gang, Liang Yan, Liu Zhaozhe, Xie Xiaodong, Yue Chengshan.
Therapeutic resistance of breast cancer stem cells and its related signaling pathway
[J]. Journal of International Oncology, 2017, 44(7): 544-546.
|
[11] |
Liu Lihua, Li Benyi.
Anti-cancer effects of Alternol and Alteronol on human cancers
[J]. Journal of International Oncology, 2017, 44(6): 452-.
|
[12] |
Lin Lin, Zhou Juying.
Molecular mechanism of G2 phase cell cycle arrest in tumor cellsLin Lin*, Zhou Juying. *Department of Radiation Oncology, First Affiliated Hospital of Soochow University, Suzhou 215000, China
[J]. Journal of International Oncology, 2017, 44(3): 186-189.
|
[13] |
Guo Chongyong, Li Yongmei, Li Bocheng, Zhou Ling, Zhang Jian, Jia Zongshi.
Expressions and clinical significances of aldehyde dehydrogenase 1 and transforming growth factor-β2 in triple negative breast cancer
[J]. Journal of International Oncology, 2017, 44(11): 801-805.
|
[14] |
郑佩.
Wnt/β-catenin signaling pathway and cancer stem cells
[J]. Journal of International Oncology, 2017, 44(11): 853-855.
|
[15] |
Xiaoliang, Luo Xu, Liu Ruming.
Expression and relationship between hepaCAM protein and multidrug resistance protein in renal carcinoma
[J]. Journal of International Oncology, 2016, 43(8): 584-587.
|